 Robin Lacour
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 5 | 2015 | 573 | 0.590 |
Why?
| | Genes, BRCA2 | 3 | 2011 | 30 | 0.500 |
Why?
| | Genes, BRCA1 | 3 | 2011 | 41 | 0.490 |
Why?
| | Uterine Neoplasms | 3 | 2011 | 113 | 0.450 |
Why?
| | Carcinosarcoma | 1 | 2011 | 23 | 0.340 |
Why?
| | Jews | 1 | 2011 | 24 | 0.340 |
Why?
| | Germ-Line Mutation | 1 | 2011 | 170 | 0.320 |
Why?
| | Genetic Testing | 2 | 2011 | 453 | 0.300 |
Why?
| | Conization | 1 | 2005 | 2 | 0.230 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2005 | 57 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2011 | 1058 | 0.220 |
Why?
| | Adenocarcinoma | 2 | 2008 | 882 | 0.190 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1742 | 0.180 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2005 | 290 | 0.180 |
Why?
| | Neoplasm Staging | 3 | 2011 | 1370 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2008 | 1377 | 0.160 |
Why?
| | Vulvar Neoplasms | 1 | 2018 | 14 | 0.140 |
Why?
| | Granular Cell Tumor | 1 | 2018 | 9 | 0.140 |
Why?
| | Endometrial Neoplasms | 2 | 2009 | 202 | 0.130 |
Why?
| | Survival Rate | 2 | 2011 | 1934 | 0.120 |
Why?
| | Carcinoid Tumor | 1 | 2015 | 23 | 0.120 |
Why?
| | Ovariectomy | 2 | 2015 | 157 | 0.110 |
Why?
| | Genital Neoplasms, Female | 1 | 2015 | 93 | 0.110 |
Why?
| | Neuroendocrine Tumors | 1 | 2015 | 108 | 0.100 |
Why?
| | Survivors | 1 | 2015 | 501 | 0.090 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2011 | 18 | 0.090 |
Why?
| | Fallopian Tubes | 1 | 2010 | 32 | 0.080 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2010 | 21 | 0.080 |
Why?
| | Carboplatin | 1 | 2011 | 146 | 0.080 |
Why?
| | Neoplasms, Unknown Primary | 1 | 2010 | 18 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2010 | 68 | 0.080 |
Why?
| | Middle Aged | 11 | 2018 | 33782 | 0.080 |
Why?
| | Hysterectomy | 2 | 2015 | 141 | 0.080 |
Why?
| | Peritoneal Neoplasms | 1 | 2011 | 97 | 0.080 |
Why?
| | Equilin | 1 | 2009 | 1 | 0.080 |
Why?
| | Paclitaxel | 1 | 2011 | 237 | 0.080 |
Why?
| | Papillomaviridae | 1 | 2010 | 132 | 0.080 |
Why?
| | Estrone | 1 | 2009 | 36 | 0.080 |
Why?
| | Genetic Counseling | 1 | 2010 | 79 | 0.080 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2009 | 50 | 0.080 |
Why?
| | Carcinoma, Endometrioid | 1 | 2009 | 50 | 0.080 |
Why?
| | Female | 14 | 2018 | 74015 | 0.080 |
Why?
| | Disease-Free Survival | 1 | 2011 | 704 | 0.080 |
Why?
| | Primary Prevention | 1 | 2010 | 199 | 0.080 |
Why?
| | Risk Reduction Behavior | 1 | 2010 | 216 | 0.070 |
Why?
| | Endometrium | 1 | 2009 | 60 | 0.070 |
Why?
| | Genes | 1 | 2009 | 227 | 0.070 |
Why?
| | Estrogen Replacement Therapy | 1 | 2009 | 148 | 0.070 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2008 | 35 | 0.070 |
Why?
| | Genetic Association Studies | 1 | 2009 | 373 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1281 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 433 | 0.060 |
Why?
| | Patient Satisfaction | 1 | 2010 | 689 | 0.060 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 429 | 0.060 |
Why?
| | Estrogens | 1 | 2009 | 370 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2011 | 3574 | 0.060 |
Why?
| | Estradiol | 1 | 2009 | 525 | 0.060 |
Why?
| | Pregnancy Trimester, Second | 1 | 2005 | 80 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2011 | 7685 | 0.050 |
Why?
| | Postoperative Period | 1 | 2005 | 355 | 0.050 |
Why?
| | Fertility | 1 | 2005 | 164 | 0.050 |
Why?
| | Delivery, Obstetric | 1 | 2005 | 159 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1487 | 0.050 |
Why?
| | Humans | 13 | 2018 | 138969 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2015 | 10921 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2009 | 1395 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2015 | 5884 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2009 | 1746 | 0.050 |
Why?
| | Postpartum Period | 1 | 2005 | 346 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 1 | 2008 | 856 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2009 | 2480 | 0.040 |
Why?
| | Cohort Studies | 1 | 2011 | 5744 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2007 | 2138 | 0.040 |
Why?
| | Aged | 4 | 2011 | 24172 | 0.040 |
Why?
| | Prospective Studies | 1 | 2011 | 7661 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 2283 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2018 | 157 | 0.030 |
Why?
| | Adult | 6 | 2015 | 38393 | 0.030 |
Why?
| | Soft Tissue Neoplasms | 1 | 2018 | 116 | 0.030 |
Why?
| | Salpingostomy | 1 | 2015 | 1 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 2994 | 0.030 |
Why?
| | Teratoma | 1 | 2015 | 118 | 0.030 |
Why?
| | Pregnancy | 1 | 2005 | 6869 | 0.020 |
Why?
| | Quality of Life | 2 | 2015 | 2962 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1482 | 0.020 |
Why?
| | Rats, Zucker | 1 | 2009 | 33 | 0.020 |
Why?
| | Microsatellite Instability | 1 | 2008 | 41 | 0.020 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2008 | 57 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2009 | 517 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 564 | 0.020 |
Why?
| | Aurora Kinases | 1 | 2007 | 28 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 761 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 984 | 0.020 |
Why?
| | Aurora Kinase A | 1 | 2007 | 55 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2005 | 15901 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2010 | 637 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2010 | 795 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1730 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1522 | 0.010 |
Why?
| | Decision Making | 1 | 2010 | 947 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3636 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1229 | 0.010 |
Why?
| | Genotype | 1 | 2007 | 1849 | 0.010 |
Why?
| | Age Factors | 1 | 2009 | 3276 | 0.010 |
Why?
| | Pilot Projects | 1 | 2007 | 1765 | 0.010 |
Why?
| | Prognosis | 1 | 2009 | 3995 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2390 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3466 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5591 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1610 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2362 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4316 | 0.010 |
Why?
| | Animals | 1 | 2009 | 37242 | 0.000 |
Why?
|
|
Lacour's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|